Sequence analysis of SARS-CoV-2 in nasopharyngeal samples from patients with COVID-19 illustrates population variation and diverse phenotypes, placing the in vitro growth properties of B.1.1.7 and B.1.351 lineage viruses in context.

Authors

Tessa Prince

Published

March 30, 2021

Add a comment...

Supporters

Support the authors with ResearchCoin

Preprint Server

Topics

DOI

10.1101/2021.03.30.437704

License

cc-no

Sequence analysis of SARS-CoV-2 in nasopharyngeal samples from patients with COVID-19 illustrates population variation and diverse phenotypes, placing the in vitro growth properties of B.1.1.7 and B.1.351 lineage viruses in context.

Authors

Tessa Prince

Published

March 30, 2021

Add a comment...

Supporters

Support the authors with ResearchCoin

Preprint Server

Topics

DOI

10.1101/2021.03.30.437704

License

cc-no

Supporters

Support the authors with ResearchCoin

Preprint Server

Topics

DOI

10.1101/2021.03.30.437704

License

cc-no

Paper

Paper

Paper

Paper

Sequence analysis of SARS-CoV-2 in nasopharyngeal samples from patients with COVID-19 illustrates population variation and diverse phenotypes, placing the in vitro growth properties of B.1.1.7 and B.1.351 lineage viruses in context.

Supporters

Preprint Server

Topics

DOI

License

Sequence analysis of SARS-CoV-2 in nasopharyngeal samples from patients with COVID-19 illustrates population variation and diverse phenotypes, placing the in vitro growth properties of B.1.1.7 and B.1.351 lineage viruses in context.

Supporters

Preprint Server

Topics

DOI

License

Supporters

Preprint Server

Topics

DOI

License